HEADER TRANSFERASE 07-SEP-05 2C0T TITLE SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-641359 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE HCK; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SH3-SH2-SH1, RESIDUES 80-525; COMPND 5 SYNONYM: HAEMATOPOETIC CELL KINASE HCK, P59-HCK/P60-HCK HEMOPOIETIC COMPND 6 CELL KINASE; COMPND 7 EC: 2.7.1.112; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: SRC NUMBERING USED. ADD 20 TO THE RESIDUE NUMBERS IN COMPND 11 THIS ENTRY TO OBTAIN ACTUAL HUMAN HCK RESIDUE NUMBERS. RESIDUE Y501 COMPND 12 (HCK Y521) IS PHOSPHORYLATED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: LYMPHOCYTE; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBC HCK002 KEYWDS TRANSFERASE, ATP-BINDING, KINASE, LIPOPROTEIN, MYRISTATE, NUCLEOTIDE- KEYWDS 2 BINDING, PALMITATE, SH2 DOMAIN, SH3 DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR D.W.BORHANI,A.BURCHAT,D.J.CALDERWOOD,G.C.HIRST,B.LI,A.LOEW REVDAT 7 16-OCT-24 2C0T 1 REMARK REVDAT 6 13-DEC-23 2C0T 1 LINK REVDAT 5 08-MAY-19 2C0T 1 REMARK REVDAT 4 06-MAR-19 2C0T 1 REMARK LINK REVDAT 3 13-JUL-11 2C0T 1 VERSN REVDAT 2 24-FEB-09 2C0T 1 VERSN REVDAT 1 20-SEP-06 2C0T 0 JRNL AUTH A.BURCHAT,D.W.BORHANI,D.J.CALDERWOOD,G.C.HIRST,B.LI, JRNL AUTH 2 R.F.STACHLEWITZ JRNL TITL DISCOVERY OF A-770041, A SRC-FAMILY SELECTIVE ORALLY ACTIVE JRNL TITL 2 LCK INHIBITOR THAT PREVENTS ORGAN ALLOGRAFT REJECTION. JRNL REF BIOORG.MED.CHEM.LETT. V. 16 118 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16216497 JRNL DOI 10.1016/J.BMCL.2005.09.039 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.W.BORHANI,D.J.CALDERWOOD,M.M.FRIEDMAN,G.C.HIRST,B.LI, REMARK 1 AUTH 2 A.K.W.LEUNG,B.MCRAE,S.RATNOFSKY,K.RITTER,W.WAEGELL REMARK 1 TITL A-420983: A POTENT, ORALLY ACTIVE INHIBITOR OF LCK WITH REMARK 1 TITL 2 EFFICACY IN A MODEL OF TRANSPLANT REJECTION REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 14 2613 2004 REMARK 1 REFN ISSN 0960-894X REMARK 1 PMID 15109663 REMARK 1 DOI 10.1016/J.BMCL.2004.02.101 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 70.8 REMARK 3 NUMBER OF REFLECTIONS : 46145 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2440 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1251 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 26.27 REMARK 3 BIN R VALUE (WORKING SET) : 0.2230 REMARK 3 BIN FREE R VALUE SET COUNT : 62 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6925 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 90 REMARK 3 SOLVENT ATOMS : 200 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 38.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.67 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.99000 REMARK 3 B22 (A**2) : -0.92000 REMARK 3 B33 (A**2) : -2.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.98000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.307 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.246 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.148 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.085 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7201 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9738 ; 1.427 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 853 ; 5.951 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 323 ;36.255 ;23.777 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1280 ;17.593 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 46 ;18.974 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1023 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5414 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2968 ; 0.205 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4838 ; 0.307 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 312 ; 0.163 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 18 ; 0.186 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 30 ; 0.180 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.137 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4419 ; 0.873 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6936 ; 1.475 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3271 ; 2.105 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2802 ; 3.344 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 59 A 115 REMARK 3 RESIDUE RANGE : A 223 A 228 REMARK 3 ORIGIN FOR THE GROUP (A): 6.4996 92.9864 10.0280 REMARK 3 T TENSOR REMARK 3 T11: 0.0924 T22: -0.1040 REMARK 3 T33: -0.0833 T12: 0.0072 REMARK 3 T13: -0.1105 T23: 0.0105 REMARK 3 L TENSOR REMARK 3 L11: 1.5318 L22: 4.4600 REMARK 3 L33: 1.7536 L12: 0.3919 REMARK 3 L13: 0.2773 L23: -1.1118 REMARK 3 S TENSOR REMARK 3 S11: -0.0588 S12: -0.0491 S13: 0.0507 REMARK 3 S21: 0.2839 S22: -0.0666 S23: -0.0915 REMARK 3 S31: -0.3579 S32: -0.0046 S33: 0.1254 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 116 A 222 REMARK 3 RESIDUE RANGE : A 495 A 505 REMARK 3 RESIDUE RANGE : A 1507 A 1507 REMARK 3 ORIGIN FOR THE GROUP (A): 26.1357 84.7112 30.5042 REMARK 3 T TENSOR REMARK 3 T11: 0.0349 T22: -0.0327 REMARK 3 T33: 0.0005 T12: -0.1017 REMARK 3 T13: -0.1541 T23: 0.1022 REMARK 3 L TENSOR REMARK 3 L11: 1.3416 L22: 2.3647 REMARK 3 L33: 4.6912 L12: -0.8392 REMARK 3 L13: 1.4149 L23: -2.1383 REMARK 3 S TENSOR REMARK 3 S11: -0.3936 S12: 0.1300 S13: 0.2513 REMARK 3 S21: 0.4993 S22: -0.1629 S23: -0.3312 REMARK 3 S31: -0.8055 S32: 0.4822 S33: 0.5564 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 229 A 494 REMARK 3 RESIDUE RANGE : A 1506 A 1506 REMARK 3 ORIGIN FOR THE GROUP (A): 3.7862 61.1039 23.0489 REMARK 3 T TENSOR REMARK 3 T11: -0.0631 T22: -0.0939 REMARK 3 T33: -0.0960 T12: 0.0131 REMARK 3 T13: 0.0067 T23: -0.0001 REMARK 3 L TENSOR REMARK 3 L11: 0.5198 L22: 0.7089 REMARK 3 L33: 2.3337 L12: -0.1450 REMARK 3 L13: 0.8718 L23: -0.5677 REMARK 3 S TENSOR REMARK 3 S11: 0.0415 S12: -0.0695 S13: -0.0408 REMARK 3 S21: -0.0754 S22: 0.0317 S23: 0.1182 REMARK 3 S31: 0.2077 S32: -0.1878 S33: -0.0731 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 59 B 115 REMARK 3 RESIDUE RANGE : B 223 B 228 REMARK 3 ORIGIN FOR THE GROUP (A): 18.4500 43.4165 77.9755 REMARK 3 T TENSOR REMARK 3 T11: 0.3941 T22: -0.0496 REMARK 3 T33: -0.1649 T12: 0.0022 REMARK 3 T13: 0.0682 T23: 0.0129 REMARK 3 L TENSOR REMARK 3 L11: 1.4146 L22: 3.7839 REMARK 3 L33: 4.4869 L12: -0.6102 REMARK 3 L13: -0.5177 L23: -1.2097 REMARK 3 S TENSOR REMARK 3 S11: 0.0868 S12: -0.0569 S13: 0.0244 REMARK 3 S21: -0.0541 S22: -0.0610 S23: 0.0860 REMARK 3 S31: 0.3145 S32: -0.0229 S33: -0.0258 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 3 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 116 B 222 REMARK 3 RESIDUE RANGE : B 495 B 505 REMARK 3 RESIDUE RANGE : B 1507 B 1507 REMARK 3 ORIGIN FOR THE GROUP (A): 30.0125 51.5201 51.9203 REMARK 3 T TENSOR REMARK 3 T11: -0.0058 T22: -0.0471 REMARK 3 T33: -0.1084 T12: 0.0475 REMARK 3 T13: 0.0033 T23: 0.0248 REMARK 3 L TENSOR REMARK 3 L11: 1.6395 L22: 2.8314 REMARK 3 L33: 4.7534 L12: -0.5784 REMARK 3 L13: -0.2387 L23: -0.5960 REMARK 3 S TENSOR REMARK 3 S11: -0.0785 S12: -0.0719 S13: 0.0665 REMARK 3 S21: 0.0736 S22: -0.0200 S23: -0.2078 REMARK 3 S31: 0.4397 S32: 0.3957 S33: 0.0986 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 229 B 494 REMARK 3 RESIDUE RANGE : B 1506 B 1506 REMARK 3 ORIGIN FOR THE GROUP (A): 10.5972 75.0032 66.4428 REMARK 3 T TENSOR REMARK 3 T11: 0.1688 T22: -0.0157 REMARK 3 T33: -0.0839 T12: 0.0913 REMARK 3 T13: 0.0230 T23: -0.0528 REMARK 3 L TENSOR REMARK 3 L11: 0.3232 L22: 0.7481 REMARK 3 L33: 4.4480 L12: -0.0651 REMARK 3 L13: -0.4012 L23: -0.3403 REMARK 3 S TENSOR REMARK 3 S11: 0.0186 S12: -0.0302 S13: 0.0305 REMARK 3 S21: 0.3132 S22: -0.0933 S23: 0.0943 REMARK 3 S31: -0.6090 S32: -0.4467 S33: 0.0747 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. THE ACTIVATION LOOP (RESIDUES A386-A398 AND B386-B398) REMARK 3 IS DISORDERED IN BOTH HCK MOLECULES (CHAINS A AND B). HCK CHAIN REMARK 3 A IS SLIGHTLY BETTER ORDERED THAN CHAIN B. SIMILARLY, THE LIGAND REMARK 3 A1506 IS BETTER ORDERED THAN B1506. SEVEN N-TERMINAL RESIDUES REMARK 3 (FROM THE EXPRESSION VECTOR, GLY-ALA -MET-GLY-SER-GLY-ILE) ARE REMARK 3 DISORDERED IN BOTH CHAINS. RESIDUE ARG-59 IS NON-NATIVE REMARK 3 (EXPRESSION VECTOR). REMARK 4 REMARK 4 2C0T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-SEP-05. REMARK 100 THE DEPOSITION ID IS D_1290025561. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAR-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52558 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 75.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 24.7 REMARK 200 DATA REDUNDANCY IN SHELL : 1.80 REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1AD5 REMARK 200 REMARK 200 REMARK: INTENSITIES WERE CONVERTED TO STRUCTURE FACTORS USING CCP4 REMARK 200 PROGRAM TRUNCATE. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZATION CONDITIONS: HCK (10 REMARK 280 MG/ML IN 150 MM NACL, 20 MM TRIS.HCL PH 8.0) WAS MIXED WITH A- REMARK 280 641359 [100 MM STOCK SOLUTION OF THE MALEIC ACID SALT IN DMSO) REMARK 280 TO GIVE A FINAL A-641359 CONCENTRATION OF 1 MM. HCK/A-641359 WAS REMARK 280 THEN MIXED WITH RESERVOIR SOLUTION (12% PEG 6000, 3% 1, 5- REMARK 280 DIAMINOPENTANE, 20% GLYCEROL, 200 MM CA(OAC)2, 100 MM TRIS.HCL REMARK 280 PH 8.0) AND EQUILBRATED AGAINST THE RESERVOIR SOLUTION BY VAPOR REMARK 280 DIFFUSION (SITTING DROPS) AT 277 K., PH 8.00, VAPOR DIFFUSION, REMARK 280 SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.45450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 502 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 503 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 504 TO ILE REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLN 502 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLN 503 TO GLU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLN 504 TO ILE REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 52 REMARK 465 ALA A 53 REMARK 465 MET A 54 REMARK 465 GLY A 55 REMARK 465 SER A 56 REMARK 465 GLY A 57 REMARK 465 ILE A 58 REMARK 465 THR A 181 REMARK 465 LEU A 182 REMARK 465 ASP A 183 REMARK 465 ASN A 184 REMARK 465 GLY A 185 REMARK 465 GLY A 186 REMARK 465 GLU A 386 REMARK 465 ASP A 387 REMARK 465 ASN A 388 REMARK 465 GLU A 389 REMARK 465 TYR A 390 REMARK 465 THR A 391 REMARK 465 ALA A 392 REMARK 465 ARG A 393 REMARK 465 GLU A 394 REMARK 465 GLY A 395 REMARK 465 ALA A 396 REMARK 465 LYS A 397 REMARK 465 PHE A 398 REMARK 465 GLY B 52 REMARK 465 ALA B 53 REMARK 465 MET B 54 REMARK 465 GLY B 55 REMARK 465 SER B 56 REMARK 465 GLY B 57 REMARK 465 ILE B 58 REMARK 465 LEU B 182 REMARK 465 ASP B 183 REMARK 465 ASN B 184 REMARK 465 GLY B 185 REMARK 465 GLU B 386 REMARK 465 ASP B 387 REMARK 465 ASN B 388 REMARK 465 GLU B 389 REMARK 465 TYR B 390 REMARK 465 THR B 391 REMARK 465 ALA B 392 REMARK 465 ARG B 393 REMARK 465 GLU B 394 REMARK 465 GLY B 395 REMARK 465 ALA B 396 REMARK 465 LYS B 397 REMARK 465 PHE B 398 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 383 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 384 CG1 CG2 REMARK 470 ILE A 385 CG1 CG2 CD1 REMARK 470 ARG B 383 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 384 CG1 CG2 REMARK 470 ILE B 385 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS B 269 O HOH B 2023 2.10 REMARK 500 NE2 GLN A 214 O HOH A 2028 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 71 -11.02 -145.43 REMARK 500 GLU A 89 76.66 -101.43 REMARK 500 SER A 90 48.37 -100.01 REMARK 500 ASP A 116 -1.44 65.29 REMARK 500 THR A 155 74.50 -105.69 REMARK 500 SER A 217 -102.06 -107.74 REMARK 500 ASN A 261 49.90 39.93 REMARK 500 LYS A 262 -36.43 75.10 REMARK 500 LYS A 262 -36.94 75.10 REMARK 500 MET A 276 158.94 -49.31 REMARK 500 LEU A 291 73.97 -103.44 REMARK 500 ASN A 355 30.09 70.30 REMARK 500 ARG A 359 -3.28 69.41 REMARK 500 ASP A 360 58.34 -143.65 REMARK 500 LEU A 372 32.77 70.64 REMARK 500 VAL A 384 -60.11 -92.90 REMARK 500 ILE B 71 -11.02 -140.81 REMARK 500 HIS B 72 -162.63 -101.53 REMARK 500 GLU B 89 59.08 -110.85 REMARK 500 SER B 90 49.83 -77.89 REMARK 500 ASP B 116 10.96 56.15 REMARK 500 PRO B 140 133.57 -35.24 REMARK 500 SER B 217 -74.74 -102.34 REMARK 500 GLU B 230 143.34 -39.47 REMARK 500 LYS B 262 -29.58 76.55 REMARK 500 LEU B 291 55.50 -98.14 REMARK 500 ARG B 359 -13.86 72.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1508 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 365 OD1 REMARK 620 2 ASP A 378 OD2 79.8 REMARK 620 3 HOH A2078 O 90.9 168.9 REMARK 620 4 HOH A2079 O 74.6 84.2 99.3 REMARK 620 5 HOH A2082 O 84.0 74.7 98.5 152.3 REMARK 620 6 HOH A2084 O 156.5 97.6 88.6 128.6 72.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B1507 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 464 OE2 REMARK 620 2 GLU A 464 OE1 50.3 REMARK 620 3 GLU B 498 O 87.6 95.2 REMARK 620 4 PTR B 501 O 81.2 125.7 107.2 REMARK 620 5 HOH B2064 O 137.7 166.3 75.8 67.6 REMARK 620 6 HOH B2065 O 110.9 98.3 161.3 75.1 88.5 REMARK 620 7 HOH B2068 O 134.3 84.4 91.2 141.5 85.5 77.3 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1507 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 498 O REMARK 620 2 PTR A 501 O 108.1 REMARK 620 3 HOH A2119 O 87.6 148.4 REMARK 620 4 HOH A2123 O 173.0 73.8 87.6 REMARK 620 5 HOH A2125 O 87.0 67.6 86.7 87.6 REMARK 620 6 GLU B 464 OE2 80.3 85.5 124.8 106.7 145.0 REMARK 620 7 GLU B 464 OE1 87.7 130.3 76.0 96.1 162.1 50.1 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B1508 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 365 OD1 REMARK 620 2 ASP B 378 OD2 96.5 REMARK 620 3 HOH B2023 O 140.5 80.9 REMARK 620 4 HOH B2039 O 63.5 111.0 80.6 REMARK 620 5 HOH B2040 O 92.8 170.5 93.3 75.2 REMARK 620 6 HOH B2043 O 144.6 82.9 74.6 149.2 88.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A1507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A1508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B1507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B1508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L3G A1506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L3G B1506 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AD5 RELATED DB: PDB REMARK 900 SRC FAMILY KINASE HCK-AMP-PNP COMPLEX REMARK 900 RELATED ID: 1BU1 RELATED DB: PDB REMARK 900 SRC FAMILY KINASE HCK SH3 DOMAIN REMARK 900 RELATED ID: 1QCF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HCK IN COMPLEX WITH A SRC FAMILY- SELECTIVE REMARK 900 TYROSINE KINASE INHIBITOR REMARK 900 RELATED ID: 2C0I RELATED DB: PDB REMARK 900 SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-420983 REMARK 900 RELATED ID: 2C0O RELATED DB: PDB REMARK 900 SRC FAMILY KINASE HCK WITH BOUND INHIBITOR A-770041 REMARK 900 RELATED ID: 2HCK RELATED DB: PDB REMARK 900 SRC FAMILY KINASE HCK-QUERCETIN COMPLEX REMARK 900 RELATED ID: 3HCK RELATED DB: PDB REMARK 900 NMR ENSEMBLE OF THE UNCOMPLEXED HUMAN HCK SH2 DOMAIN, 20 STRUCTURES REMARK 900 RELATED ID: 4HCK RELATED DB: PDB REMARK 900 HUMAN HCK SH3 DOMAIN, NMR, 25 STRUCTURES REMARK 900 RELATED ID: 5HCK RELATED DB: PDB REMARK 900 HUMAN HCK SH3 DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PROTEIN CRYSTALLIZED INCLUDED EIGHT NON-NATIVE REMARK 999 N-TERMINAL RESIDUES: GLY-ALA-MET-GLY-SER-GLY-ILE-ARG. REMARK 999 Q502E, Q503E, Q504I TRIPLE MUTANT TO INCREASE THE REMARK 999 PHOSPHORYLATION OF Y501 (ALL SRC NUMBERING). DBREF 2C0T A 52 59 PDB 2C0T 2C0T 52 59 DBREF 2C0T A 60 505 UNP P08631 HCK_HUMAN 80 525 DBREF 2C0T B 52 59 PDB 2C0T 2C0T 52 59 DBREF 2C0T B 60 505 UNP P08631 HCK_HUMAN 80 525 SEQADV 2C0T GLU A 502 UNP P08631 GLN 522 ENGINEERED MUTATION SEQADV 2C0T GLU A 503 UNP P08631 GLN 523 ENGINEERED MUTATION SEQADV 2C0T ILE A 504 UNP P08631 GLN 524 ENGINEERED MUTATION SEQADV 2C0T GLU B 502 UNP P08631 GLN 522 ENGINEERED MUTATION SEQADV 2C0T GLU B 503 UNP P08631 GLN 523 ENGINEERED MUTATION SEQADV 2C0T ILE B 504 UNP P08631 GLN 524 ENGINEERED MUTATION SEQRES 1 A 454 GLY ALA MET GLY SER GLY ILE ARG ILE ILE VAL VAL ALA SEQRES 2 A 454 LEU TYR ASP TYR GLU ALA ILE HIS HIS GLU ASP LEU SER SEQRES 3 A 454 PHE GLN LYS GLY ASP GLN MET VAL VAL LEU GLU GLU SER SEQRES 4 A 454 GLY GLU TRP TRP LYS ALA ARG SER LEU ALA THR ARG LYS SEQRES 5 A 454 GLU GLY TYR ILE PRO SER ASN TYR VAL ALA ARG VAL ASP SEQRES 6 A 454 SER LEU GLU THR GLU GLU TRP PHE PHE LYS GLY ILE SER SEQRES 7 A 454 ARG LYS ASP ALA GLU ARG GLN LEU LEU ALA PRO GLY ASN SEQRES 8 A 454 MET LEU GLY SER PHE MET ILE ARG ASP SER GLU THR THR SEQRES 9 A 454 LYS GLY SER TYR SER LEU SER VAL ARG ASP TYR ASP PRO SEQRES 10 A 454 ARG GLN GLY ASP THR VAL LYS HIS TYR LYS ILE ARG THR SEQRES 11 A 454 LEU ASP ASN GLY GLY PHE TYR ILE SER PRO ARG SER THR SEQRES 12 A 454 PHE SER THR LEU GLN GLU LEU VAL ASP HIS TYR LYS LYS SEQRES 13 A 454 GLY ASN ASP GLY LEU CYS GLN LYS LEU SER VAL PRO CYS SEQRES 14 A 454 MET SER SER LYS PRO GLN LYS PRO TRP GLU LYS ASP ALA SEQRES 15 A 454 TRP GLU ILE PRO ARG GLU SER LEU LYS LEU GLU LYS LYS SEQRES 16 A 454 LEU GLY ALA GLY GLN PHE GLY GLU VAL TRP MET ALA THR SEQRES 17 A 454 TYR ASN LYS HIS THR LYS VAL ALA VAL LYS THR MET LYS SEQRES 18 A 454 PRO GLY SER MET SER VAL GLU ALA PHE LEU ALA GLU ALA SEQRES 19 A 454 ASN VAL MET LYS THR LEU GLN HIS ASP LYS LEU VAL LYS SEQRES 20 A 454 LEU HIS ALA VAL VAL THR LYS GLU PRO ILE TYR ILE ILE SEQRES 21 A 454 THR GLU PHE MET ALA LYS GLY SER LEU LEU ASP PHE LEU SEQRES 22 A 454 LYS SER ASP GLU GLY SER LYS GLN PRO LEU PRO LYS LEU SEQRES 23 A 454 ILE ASP PHE SER ALA GLN ILE ALA GLU GLY MET ALA PHE SEQRES 24 A 454 ILE GLU GLN ARG ASN TYR ILE HIS ARG ASP LEU ARG ALA SEQRES 25 A 454 ALA ASN ILE LEU VAL SER ALA SER LEU VAL CYS LYS ILE SEQRES 26 A 454 ALA ASP PHE GLY LEU ALA ARG VAL ILE GLU ASP ASN GLU SEQRES 27 A 454 TYR THR ALA ARG GLU GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 28 A 454 THR ALA PRO GLU ALA ILE ASN PHE GLY SER PHE THR ILE SEQRES 29 A 454 LYS SER ASP VAL TRP SER PHE GLY ILE LEU LEU MET GLU SEQRES 30 A 454 ILE VAL THR TYR GLY ARG ILE PRO TYR PRO GLY MET SER SEQRES 31 A 454 ASN PRO GLU VAL ILE ARG ALA LEU GLU ARG GLY TYR ARG SEQRES 32 A 454 MET PRO ARG PRO GLU ASN CYS PRO GLU GLU LEU TYR ASN SEQRES 33 A 454 ILE MET MET ARG CYS TRP LYS ASN ARG PRO GLU GLU ARG SEQRES 34 A 454 PRO THR PHE GLU TYR ILE GLN SER VAL LEU ASP ASP PHE SEQRES 35 A 454 TYR THR ALA THR GLU SER GLN PTR GLU GLU ILE PRO SEQRES 1 B 454 GLY ALA MET GLY SER GLY ILE ARG ILE ILE VAL VAL ALA SEQRES 2 B 454 LEU TYR ASP TYR GLU ALA ILE HIS HIS GLU ASP LEU SER SEQRES 3 B 454 PHE GLN LYS GLY ASP GLN MET VAL VAL LEU GLU GLU SER SEQRES 4 B 454 GLY GLU TRP TRP LYS ALA ARG SER LEU ALA THR ARG LYS SEQRES 5 B 454 GLU GLY TYR ILE PRO SER ASN TYR VAL ALA ARG VAL ASP SEQRES 6 B 454 SER LEU GLU THR GLU GLU TRP PHE PHE LYS GLY ILE SER SEQRES 7 B 454 ARG LYS ASP ALA GLU ARG GLN LEU LEU ALA PRO GLY ASN SEQRES 8 B 454 MET LEU GLY SER PHE MET ILE ARG ASP SER GLU THR THR SEQRES 9 B 454 LYS GLY SER TYR SER LEU SER VAL ARG ASP TYR ASP PRO SEQRES 10 B 454 ARG GLN GLY ASP THR VAL LYS HIS TYR LYS ILE ARG THR SEQRES 11 B 454 LEU ASP ASN GLY GLY PHE TYR ILE SER PRO ARG SER THR SEQRES 12 B 454 PHE SER THR LEU GLN GLU LEU VAL ASP HIS TYR LYS LYS SEQRES 13 B 454 GLY ASN ASP GLY LEU CYS GLN LYS LEU SER VAL PRO CYS SEQRES 14 B 454 MET SER SER LYS PRO GLN LYS PRO TRP GLU LYS ASP ALA SEQRES 15 B 454 TRP GLU ILE PRO ARG GLU SER LEU LYS LEU GLU LYS LYS SEQRES 16 B 454 LEU GLY ALA GLY GLN PHE GLY GLU VAL TRP MET ALA THR SEQRES 17 B 454 TYR ASN LYS HIS THR LYS VAL ALA VAL LYS THR MET LYS SEQRES 18 B 454 PRO GLY SER MET SER VAL GLU ALA PHE LEU ALA GLU ALA SEQRES 19 B 454 ASN VAL MET LYS THR LEU GLN HIS ASP LYS LEU VAL LYS SEQRES 20 B 454 LEU HIS ALA VAL VAL THR LYS GLU PRO ILE TYR ILE ILE SEQRES 21 B 454 THR GLU PHE MET ALA LYS GLY SER LEU LEU ASP PHE LEU SEQRES 22 B 454 LYS SER ASP GLU GLY SER LYS GLN PRO LEU PRO LYS LEU SEQRES 23 B 454 ILE ASP PHE SER ALA GLN ILE ALA GLU GLY MET ALA PHE SEQRES 24 B 454 ILE GLU GLN ARG ASN TYR ILE HIS ARG ASP LEU ARG ALA SEQRES 25 B 454 ALA ASN ILE LEU VAL SER ALA SER LEU VAL CYS LYS ILE SEQRES 26 B 454 ALA ASP PHE GLY LEU ALA ARG VAL ILE GLU ASP ASN GLU SEQRES 27 B 454 TYR THR ALA ARG GLU GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 28 B 454 THR ALA PRO GLU ALA ILE ASN PHE GLY SER PHE THR ILE SEQRES 29 B 454 LYS SER ASP VAL TRP SER PHE GLY ILE LEU LEU MET GLU SEQRES 30 B 454 ILE VAL THR TYR GLY ARG ILE PRO TYR PRO GLY MET SER SEQRES 31 B 454 ASN PRO GLU VAL ILE ARG ALA LEU GLU ARG GLY TYR ARG SEQRES 32 B 454 MET PRO ARG PRO GLU ASN CYS PRO GLU GLU LEU TYR ASN SEQRES 33 B 454 ILE MET MET ARG CYS TRP LYS ASN ARG PRO GLU GLU ARG SEQRES 34 B 454 PRO THR PHE GLU TYR ILE GLN SER VAL LEU ASP ASP PHE SEQRES 35 B 454 TYR THR ALA THR GLU SER GLN PTR GLU GLU ILE PRO MODRES 2C0T PTR A 501 TYR O-PHOSPHOTYROSINE MODRES 2C0T PTR B 501 TYR O-PHOSPHOTYROSINE HET PTR A 501 16 HET PTR B 501 16 HET L3G A1506 43 HET CA A1507 1 HET CA A1508 1 HET L3G B1506 43 HET CA B1507 1 HET CA B1508 1 HETNAM PTR O-PHOSPHOTYROSINE HETNAM L3G N-(4-{4-AMINO-1-[1-(TETRAHYDRO-2H-PYRAN-4-YL)PIPERIDIN- HETNAM 2 L3G 4-YL]-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL}-2- HETNAM 3 L3G METHOXYPHENYL)-1-METHYL-1H-INDOLE-2-CARBOXAMIDE HETNAM CA CALCIUM ION HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 L3G 2(C32 H36 N8 O3) FORMUL 4 CA 4(CA 2+) FORMUL 9 HOH *200(H2 O) HELIX 1 1 SER A 117 GLU A 121 5 5 HELIX 2 2 SER A 129 ALA A 139 1 11 HELIX 3 3 THR A 197 LYS A 206 1 10 HELIX 4 4 PRO A 237 GLU A 239 5 3 HELIX 5 5 SER A 277 LYS A 289 1 13 HELIX 6 6 SER A 319 SER A 326 1 8 HELIX 7 7 GLU A 328 GLN A 332 5 5 HELIX 8 8 PRO A 333 ARG A 354 1 22 HELIX 9 9 ARG A 362 ALA A 364 5 3 HELIX 10 10 GLY A 380 ILE A 385 1 6 HELIX 11 11 PRO A 399 THR A 403 5 5 HELIX 12 12 ALA A 404 GLY A 411 1 8 HELIX 13 13 THR A 414 THR A 431 1 18 HELIX 14 14 SER A 441 GLY A 452 1 12 HELIX 15 15 PRO A 462 TRP A 473 1 12 HELIX 16 16 ARG A 476 ARG A 480 5 5 HELIX 17 17 THR A 482 ASP A 492 1 11 HELIX 18 18 ALA A 496 GLN A 500 5 5 HELIX 19 19 SER B 117 GLU B 121 5 5 HELIX 20 20 SER B 129 ALA B 139 1 11 HELIX 21 21 THR B 197 GLY B 208 1 12 HELIX 22 22 PRO B 237 GLU B 239 5 3 HELIX 23 23 SER B 277 LEU B 291 1 15 HELIX 24 24 SER B 319 SER B 326 1 8 HELIX 25 25 GLU B 328 GLN B 332 5 5 HELIX 26 26 PRO B 333 ARG B 354 1 22 HELIX 27 27 ARG B 362 ALA B 364 5 3 HELIX 28 28 ALA B 404 PHE B 410 1 7 HELIX 29 29 THR B 414 THR B 431 1 18 HELIX 30 30 SER B 441 GLY B 452 1 12 HELIX 31 31 PRO B 462 TRP B 473 1 12 HELIX 32 32 ARG B 476 ARG B 480 5 5 HELIX 33 33 THR B 482 ASP B 492 1 11 HELIX 34 34 ALA B 496 GLN B 500 5 5 SHEET 1 AA 5 GLU A 104 PRO A 108 0 SHEET 2 AA 5 TRP A 93 SER A 98 -1 O TRP A 94 N ILE A 107 SHEET 3 AA 5 GLN A 83 SER A 90 -1 O VAL A 85 N ARG A 97 SHEET 4 AA 5 ILE A 61 ALA A 64 -1 O VAL A 62 N MET A 84 SHEET 5 AA 5 VAL A 112 ARG A 114 -1 O ALA A 113 N VAL A 63 SHEET 1 AB 4 PHE A 124 PHE A 125 0 SHEET 2 AB 4 PHE A 147 ASP A 151 1 O ILE A 149 N PHE A 125 SHEET 3 AB 4 TYR A 159 ASP A 167 -1 O SER A 160 N ARG A 150 SHEET 4 AB 4 GLY A 171 LYS A 178 -1 O GLY A 171 N ASP A 167 SHEET 1 AC 5 LEU A 241 GLY A 250 0 SHEET 2 AC 5 GLY A 253 TYR A 260 -1 O GLY A 253 N GLY A 250 SHEET 3 AC 5 THR A 264 MET A 271 -1 O THR A 264 N TYR A 260 SHEET 4 AC 5 TYR A 309 GLU A 313 -1 O ILE A 310 N LYS A 269 SHEET 5 AC 5 LEU A 299 VAL A 303 -1 N HIS A 300 O ILE A 311 SHEET 1 AD 2 ILE A 366 VAL A 368 0 SHEET 2 AD 2 CYS A 374 ILE A 376 -1 O LYS A 375 N LEU A 367 SHEET 1 BA 5 GLU B 104 PRO B 108 0 SHEET 2 BA 5 TRP B 93 SER B 98 -1 O TRP B 94 N ILE B 107 SHEET 3 BA 5 GLN B 83 GLU B 88 -1 O VAL B 85 N ARG B 97 SHEET 4 BA 5 ILE B 61 ALA B 64 -1 O VAL B 62 N MET B 84 SHEET 5 BA 5 VAL B 112 ARG B 114 -1 O ALA B 113 N VAL B 63 SHEET 1 BB 4 PHE B 124 PHE B 125 0 SHEET 2 BB 4 PHE B 147 ASP B 151 1 O ILE B 149 N PHE B 125 SHEET 3 BB 4 TYR B 159 ASP B 167 -1 O SER B 160 N ARG B 150 SHEET 4 BB 4 GLY B 171 ILE B 179 -1 O GLY B 171 N ASP B 167 SHEET 1 BC 2 PHE B 187 TYR B 188 0 SHEET 2 BC 2 THR B 194 PHE B 195 -1 O PHE B 195 N PHE B 187 SHEET 1 BD 5 LEU B 241 ALA B 249 0 SHEET 2 BD 5 GLU B 254 TYR B 260 -1 O VAL B 255 N LEU B 247 SHEET 3 BD 5 THR B 264 MET B 271 -1 O THR B 264 N TYR B 260 SHEET 4 BD 5 ILE B 308 GLU B 313 -1 O ILE B 308 N MET B 271 SHEET 5 BD 5 LEU B 299 VAL B 303 -1 N HIS B 300 O ILE B 311 SHEET 1 BE 2 ILE B 366 VAL B 368 0 SHEET 2 BE 2 CYS B 374 ILE B 376 -1 O LYS B 375 N LEU B 367 LINK C GLN A 500 N PTR A 501 1555 1555 1.33 LINK C PTR A 501 N GLU A 502 1555 1555 1.33 LINK C GLN B 500 N PTR B 501 1555 1555 1.34 LINK C PTR B 501 N GLU B 502 1555 1555 1.33 LINK OD1 ASN A 365 CA CA A1508 1555 1555 2.34 LINK OD2 ASP A 378 CA CA A1508 1555 1555 2.32 LINK OE2 GLU A 464 CA CA B1507 1555 1555 2.46 LINK OE1 GLU A 464 CA CA B1507 1555 1555 2.64 LINK O GLU A 498 CA CA A1507 1555 1555 2.19 LINK O PTR A 501 CA CA A1507 1555 1555 2.55 LINK CA CA A1507 O HOH A2119 1555 1555 2.14 LINK CA CA A1507 O HOH A2123 1555 1555 2.23 LINK CA CA A1507 O HOH A2125 1555 1555 2.19 LINK CA CA A1507 OE2 GLU B 464 1555 1555 2.36 LINK CA CA A1507 OE1 GLU B 464 1555 1555 2.75 LINK CA CA A1508 O HOH A2078 1555 1555 2.24 LINK CA CA A1508 O HOH A2079 1555 1555 2.25 LINK CA CA A1508 O HOH A2082 1555 1555 2.16 LINK CA CA A1508 O HOH A2084 1555 1555 2.42 LINK OD1 ASN B 365 CA CA B1508 1555 1555 2.61 LINK OD2 ASP B 378 CA CA B1508 1555 1555 2.18 LINK O GLU B 498 CA CA B1507 1555 1555 2.29 LINK O PTR B 501 CA CA B1507 1555 1555 2.38 LINK CA CA B1507 O HOH B2064 1555 1555 2.14 LINK CA CA B1507 O HOH B2065 1555 1555 2.29 LINK CA CA B1507 O HOH B2068 1555 1555 2.33 LINK CA CA B1508 O HOH B2023 1555 1555 2.57 LINK CA CA B1508 O HOH B2039 1555 1555 2.18 LINK CA CA B1508 O HOH B2040 1555 1555 2.29 LINK CA CA B1508 O HOH B2043 1555 1555 2.60 CISPEP 1 GLU A 306 PRO A 307 0 2.04 CISPEP 2 GLU B 306 PRO B 307 0 -6.66 SITE 1 AC1 6 GLU A 498 PTR A 501 HOH A2119 HOH A2123 SITE 2 AC1 6 HOH A2125 GLU B 464 SITE 1 AC2 6 ASN A 365 ASP A 378 HOH A2078 HOH A2079 SITE 2 AC2 6 HOH A2082 HOH A2084 SITE 1 AC3 6 GLU A 464 GLU B 498 PTR B 501 HOH B2064 SITE 2 AC3 6 HOH B2065 HOH B2068 SITE 1 AC4 6 ASN B 365 ASP B 378 HOH B2023 HOH B2039 SITE 2 AC4 6 HOH B2040 HOH B2043 SITE 1 AC5 17 LEU A 247 VAL A 255 ALA A 267 VAL A 268 SITE 2 AC5 17 LYS A 269 PHE A 281 VAL A 297 ILE A 310 SITE 3 AC5 17 THR A 312 GLU A 313 PHE A 314 MET A 315 SITE 4 AC5 17 ASP A 322 LEU A 367 ASP A 378 PHE A 379 SITE 5 AC5 17 HOH A2128 SITE 1 AC6 17 LEU B 247 VAL B 255 ALA B 267 VAL B 268 SITE 2 AC6 17 LYS B 269 MET B 288 VAL B 297 ILE B 310 SITE 3 AC6 17 THR B 312 GLU B 313 MET B 315 ASP B 322 SITE 4 AC6 17 LEU B 367 ASP B 378 PHE B 379 LEU B 381 SITE 5 AC6 17 HOH B2071 CRYST1 48.861 72.909 180.002 90.00 95.87 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020466 0.000000 0.002104 0.00000 SCALE2 0.000000 0.013716 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005585 0.00000 MTRIX1 1 0.943572 0.024560 -0.330255 13.22352 1 MTRIX2 1 0.021373 -0.999683 -0.013277 136.30692 1 MTRIX3 1 -0.330476 0.005469 -0.943798 89.06069 1